These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 15757543)
1. [Mucoepidermoid carcinoma of nasopharynx: a report of twelve cases]. Qiu F; Hua YJ; Guo L; He JH; Qiu XL; Hong MH Ai Zheng; 2005 Mar; 24(3):362-4. PubMed ID: 15757543 [TBL] [Abstract][Full Text] [Related]
2. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer. Guo ZM; Liu WW; He JH Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979 [TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of sixteen cases of lymphoepithelial carcinoma of salivary gland]. Zhang Q; Qing J; Wei MW; Guo ZM Ai Zheng; 2005 Nov; 24(11):1384-7. PubMed ID: 16552968 [TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with positive Epstein-Barr virus serologic status in the absence of nasopharyngeal carcinoma in Hong Kong. Lo S; Ho WK; Wei WI Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):770-2. PubMed ID: 15210561 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) serology for predicting distant metastases in a white juvenile patient with nasopharyngeal carcinoma and no clinical response to EBV lytic induction therapy. Stevens SJ; Zwaan CM; Verkuijlen SA; Middeldorp JM Head Neck; 2006 Nov; 28(11):1040-5. PubMed ID: 16933315 [TBL] [Abstract][Full Text] [Related]
6. [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients]. Jiang LN; Dai LC; He JF; Chen YW; Ma ZH Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):30-2. PubMed ID: 16816858 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma]. Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265 [TBL] [Abstract][Full Text] [Related]
8. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis]. Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678 [TBL] [Abstract][Full Text] [Related]
10. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas]. Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549 [TBL] [Abstract][Full Text] [Related]
11. Primary salivary gland-type carcinomas of the nasopharynx: prognostic factors and outcome. Cao CN; Zhang XM; Luo JW; Xu GZ; Gao L; Li SY; Xiao JP; Yi JL; Huang XD; Liu SY; Xu ZG; Tang PZ Int J Oral Maxillofac Surg; 2012 Aug; 41(8):958-64. PubMed ID: 22579955 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842 [TBL] [Abstract][Full Text] [Related]
13. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan. Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547 [TBL] [Abstract][Full Text] [Related]
14. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420 [TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal carcinoma in situ (NPCIS)--pathologic and clinical perspectives. Pak MW; To KF; Lo YM; Chan LY; Tong JH; Lo KW; van Hasselt CA Head Neck; 2002 Nov; 24(11):989-95. PubMed ID: 12410533 [TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis and long-term follow up study of asymptomatic nasopharyngeal carcinoma patients]. Ji MF; Guo YQ; Zheng SA; Liang JS; Wang DK; Ou XT Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):53-6. PubMed ID: 12778770 [TBL] [Abstract][Full Text] [Related]
17. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
18. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area. Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178 [TBL] [Abstract][Full Text] [Related]
19. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma. Chang KP; Hao SP; Lin SY; Ueng SH; Pai PC; Tseng CK; Hsueh C; Hsieh MS; Yu JS; Tsang NM Laryngoscope; 2006 Apr; 116(4):541-6. PubMed ID: 16585856 [TBL] [Abstract][Full Text] [Related]
20. Different therapeutic strategies in primary salivary gland-type nasopharyngeal carcinomas. Liu TR; Chen FJ; Zhang GP; Yang AK Curr Opin Otolaryngol Head Neck Surg; 2011 Apr; 19(2):87-91. PubMed ID: 21297475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]